Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

1.48p
   
  • Change Today:
    -0.040p
  • 52 Week High: 3.96
  • 52 Week Low: 1.17
  • Currency: UK Pounds
  • Shares Issued: 1,341.82m
  • Volume: 2,259,529
  • Market Cap: £19.79m
  • RiskGrade: 340

Regulatory News

Clinical Hold Lift Plan is accepted by FDA 14-Sep-2023 07:00 RNS
Full FDA Review for HEMO-CAR-T IND 10-Jul-2023 07:00 RNS
Result of Annual General Meeting 30-Jun-2023 16:07 RNS
Posting of Annual Report & Notice of AGM 02-Jun-2023 14:01 RNS
Clinical Hold on IND for HEMO-CAR-T 02-Jun-2023 11:24 RNS
Submission of IND for HEMO-CAR-T 09-May-2023 07:00 RNS
Equity Incentive Pool Increase and Option Grant 28-Apr-2023 10:05 RNS
Final Results for the Year Ended 31 December 2022 28-Apr-2023 07:00 RNS
Total Voting Rights 28-Feb-2023 07:00 RNS
Admission of Shares to Official List 07-Feb-2023 14:30 RNS
Second Price Monitoring Extn 26-Jan-2023 09:05 RNS
Price Monitoring Extension 26-Jan-2023 09:00 RNS
Placing to Raise £4,056,250 26-Jan-2023 07:00 RNS
Second Price Monitoring Extn 16-Jan-2023 16:40 RNS
Price Monitoring Extension 16-Jan-2023 16:35 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 1.48p
Change Today -0.040p
% Change -2.64 %
52 Week High 3.96
52 Week Low 1.17
Volume 2,259,529
Shares Issued 1,341.82m
Market Cap £19.79m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
49.14% below the market average49.14% below the market average49.14% below the market average49.14% below the market average49.14% below the market average
72.55% below the sector average72.55% below the sector average72.55% below the sector average72.55% below the sector average72.55% below the sector average
Price Trend
42.68% below the market average42.68% below the market average42.68% below the market average42.68% below the market average42.68% below the market average
18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 24-May-2024

Time Volume / Share Price
16:24 12,570 @ 1.49p
16:04 6,140 @ 1.49p
15:38 201 @ 1.50p
14:39 265 @ 1.50p
14:32 649 @ 1.45p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page